Institut de veille sanitaire

About: Institut de veille sanitaire is a healthcare organization based out in Saint-Maurice, France. It is known for research contribution in the topics: Population & Public health. The organization has 1055 authors who have published 1547 publications receiving 56945 citations. The organization is also known as: INVS & InVS.

Long-term persistence of knee pain and occupational exposure in two large prospective cohorts of workers.

Abstract: Background The persistence of knee pain (KP) and its relationship with occupational factors were investigated in two prospective cohorts of French workers: retirees of the Gazel cohort and workers in the Cosali cohort.

Epidemiology of bacterial meningitis in France in 1999

Abstract: En France, deux sources de donnees, la declaration obligatoire et le reseau de laboratoire hospitalier EPIBAC, permettent de suivre l'evolution de l'incidence des meningites bacteriennes (MB) et de connaitre la frequence relative des bacteries responsables. En 1999, plus de 1 000 cas de MB ont ete recenses en France. Les micro-organismes les plus frequemment isoles etaient le pneumocoque : 46 %, le meningocoque : 32 %, et le streptocoque B : 11 %. Les Listeria et H. influenzae representaient 6 % et 5 % des cas respectivement. L'incidence, pour 100 000 habitants en 1999, des meningites a pneumocoques (0,81), a streptocoques du groupe B (0,19) et des meningites tuberculeuses (0,17) etait stable depuis 1992. L'incidence des meningites a meningocoques (0,58) a augmente depuis 1995. L'incidence des meningites a Listeria (0,10) et a H. influenzae (0,08) a diminue regulierement depuis 1992. L'impact des mesures de prevention des meningites a H. influenzae B et a Listeria a ete clairement demontre par la diminution de l'incidence des meningites liees a ces bacteries.

Déclaration des événements indésirables graves liés aux soins à l'Institut de Veille sanitaire

Abstract: The code de sante publique imposes to all health professionals an obligation to declare serious and undesirable events following cares applied during treatment investigations or prevention actions. An experimentation has been installed under the responsibility of the Institut de Veille sanitaire further to the 9 August 2004 bill. It aims to define how to declare undesirable adverse events to test its feasibility, its efficiency and to identify the necessary conditions to widespread its modalities. The field of these experimentations concerns all health professionals, working in public hospital or in private practice. The definition of undesirable adverse events should be clarified. Different ways to declare these events will be discussed with SFRO (Societe francaise de radiotherapie oncologique) to improve the current management of incidents and adverse events.